Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selecting use of proteasome inhibitors based on NF-κB2 sequence

Selecting use of proteasome inhibitors based on NF-κB2 sequence

US Patent 9856534 · Granted Jan 2, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acids for cell recognition and integration2025
Classifiers of NF-κB pathway activation, devices, and methods of use thereof2018